Skip to main content
Passa alla visualizzazione normale.


Pari opportunità

GIUSEPPE BADALAMENTI

Gemcitabine plus metronoic capecitabine as second/third line chemotherapy in advanced adrenocortical carcinoma. A multicenter phase II trial.

  • Authors: Paola Sperone, Anna Ferrero, Fulvia Daffara, Marco Volante, Mauo Papotti, Daniele Santini, Bruo Vincenzi, Chiara Intrivici, Giuseppe Badalamenti, Sabrina Del Buono, Riccardo Ratti, Alberto Angeli, Luigi Dogliotti, Massimo Terzolo, Alfredo Berruti
  • Publication year: 2008
  • Type: Abstract in rivista (Abstract in rivista)
  • Key words: adrenocortical carcinoma chemotherapy
  • OA Link: http://hdl.handle.net/10447/44526